2m 2m 2m 2m 2m 2m 2m
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$68.72-$0.20 (-0.30%)
Price as of Jun 23, 2026 7:09 PM EDT- $13.5BMarket Cap
- 63.41%1-Year Change
- BiotechnologyIndustry
BRIDGEBIO PHARMA (BBIO)
$68.72-$0.20 (-0.30%)
Earnings Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -2.71% | ||
12-Month Momentum | 63.48% | ||
3-Month Risk Adjusted Momentum | -15.39% | ||
12-Month Risk Adjusted Momentum | 139.72% |
True Yield
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.57% | ||
Net Debt Paydown Yield | -0.52% |
Financial Health Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |